Saudi Arabia sees highest deal value on record at USD 72.5 billion

Mergermarket, the leading provider of M&A data and intelligence, has today released research showing that Saudi Arabia saw a jump in M&A volume and value (14 deals worth USD 72.6bn) during the first half of 2019, due to the blockbuster USD 70bn SABIC deal announced in 1Q19, the region’s highest value deal on record and the second largest industrials and chemicals deal globally. 

Dealcast: Allergan reaction

The European Commission (EC) is reviewing AbbVie’s [NYSE:ABBV] proposed acquisition of Botox producer Allergan [NYSE:AGN]. The merging parties have already pledged to divest such products as brazikumab, a drug under development for ulcerative colitis and Crohn’s disease, and Zenpep (pancrelipase), which treats a pancreatic disorder, but the EC may want more changes if it is to approve the deal. Dealreporter’s Pablo Mayo Cerqueiro and Mergermarket’s Mintoi Chessa-Florea joined us to discuss how the EC’s review is likely to go.

Load more